Purpose: Cognitive impairment is a common consequence of stroke and has direct
implications for poststroke functioning and quality of life, including the ability to maintain a …

Stroke is a leading cause of the adult disability epidemic in the United States, with a major
contribution from poststroke cognitive impairment and dementia (PSCID), the rates of which …

Subarachnoid haemorrhage (SAH) is a common cerebrovascular disease with high
disability and mortality rates worldwide. The pathophysiological mechanisms involved in an …

OBJECTIVE Clazosentan has been investigated globally for the prevention of cerebral
vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). The authors evaluated its …

Stroke is considered to be an acute cerebrovascular disease, including ischemic stroke and
hemorrhagic stroke. The high incidence and poor prognosis of stroke suggest that it is a …

Background and Purpose—To identify predictors of in-hospital mortality in patients with
aneurysmal subarachnoid hemorrhage and to estimate their impact. Methods …

Background Subarachnoid hemorrhage (SAH) is associated with high rates of morbidity,
including neurological and cognitive deficits that may be difficult to identify and quantify. This …

Background For patients presenting with an aneurysmal subarachnoid hemorrhage (aSAH),
delayed cerebral ischemia (DCI) is a significant cause of morbidity and mortality. The …

Interleukin 6 (IL-6) is a prominent proinflammatory cytokine. Neuroinflammation in general,
and IL-6 signaling in particular, appear to play a major role in the pathobiology and …

OBJECTIVE Ischemic complications account for significant patient morbidity following
aneurysmal subarachnoid hemorrhage (aSAH). The Prevention and Treatment of …